Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Citations for PubMed (Select 24386373)

1.

WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.

Liu Y, El-Serag HB, Jiao L, Lee J, Moore D, Franco LM, Tavakoli-Tabasi S, Tsavachidis S, Kuzniarek J, Ramsey DJ, White DL.

PLoS One. 2013 Dec 30;8(12):e84407. doi: 10.1371/journal.pone.0084407. eCollection 2013.

2.

Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients.

Tyson GL, Richardson PA, White DL, Kuzniarek J, Ramsey DJ, Tavakoli-Tabasi S, El-Serag HB.

J Clin Gastroenterol. 2013 Jul;47(6):545-52. doi: 10.1097/MCG.0b013e31827244d9.

3.

Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

White DL, Liu Y, Garcia J, El-Serag HB, Jiao L, Tsavachidis S, Franco LM, Lee JS, Tavakoli-Tabasi S, Moore D, Goldman R, Kuzniarek J, Ramsey DJ, Kanwal F, Marcelli M.

Int J Mol Epidemiol Genet. 2014 Oct 22;5(3):164-76. eCollection 2014.

4.

Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.

White DL, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey DJ, El-Serag HB.

Hepatology. 2012 Mar;55(3):759-68. doi: 10.1002/hep.24618. Epub 2011 Dec 14.

5.

Finasteride and methadone use and risk of advanced hepatitis C related liver disease.

White DL, Hashmi A, Ramsey DJ, Kuzniarek J, Tavakoli-Tabasi S, El-Serag HB.

Dig Dis Sci. 2012 Nov;57(11):3004-10. doi: 10.1007/s10620-012-2231-3. Epub 2012 Jun 5.

PMID:
22669204
6.

The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males.

White DL, Tavakoli-Tabasi S, Kanwal F, Ramsey DJ, Hashmi A, Kuzniarek J, Patel P, Francis J, El-Serag HB.

Aliment Pharmacol Ther. 2013 Jul;38(1):28-37. doi: 10.1111/apt.12341. Epub 2013 May 26.

7.

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.

Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I, Abel L, Pol S, Dufour JF, Negro F; Swiss Hepatitis C Cohort Study Group; ANRS HC EP 26 Genoscan Study Group.

Hepatology. 2012 Feb;55(2):384-94. doi: 10.1002/hep.24678. Epub 2011 Dec 16.

PMID:
22180014
8.

Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Gehrke SG, Stremmel W, Mathes I, Riedel HD, Bents K, Kallinowski B.

J Mol Med (Berl). 2003 Dec;81(12):780-7. Epub 2003 Oct 14.

PMID:
14557859
9.

High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

Aroucha DC, do Carmo RF, Moura P, Silva JL, Vasconcelos LR, Cavalcanti MS, Muniz MT, Aroucha ML, Siqueira ER, Cahú GG, Pereira LM, Coêlho MR.

Cytokine. 2013 Jun;62(3):421-5. doi: 10.1016/j.cyto.2013.03.024. Epub 2013 Apr 16.

PMID:
23602201
10.

Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.

Shao RX, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, Shiina S, Taniguchi H, Moriyama M, Kawabe T, Omata M.

World J Gastroenterol. 2005 Apr 7;11(13):1995-9.

11.

CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Silvestri L, Sonzogni L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Leveri M, Cividini A, Mondelli MU, Civardi E, Silini EM.

Int J Cancer. 2003 Apr 10;104(3):310-7.

PMID:
12569554
12.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

13.

Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.

White DL, Richardson PA, Al-Saadi M, Fitzgerald SJ, Green L, Amaratunge C, Anand M, El-Serag HB.

Dig Dis Sci. 2011 Jun;56(6):1835-47. doi: 10.1007/s10620-010-1505-x. Epub 2010 Dec 28.

14.

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.

D'Ambrosio R, Aghemo A, De Francesco R, Rumi MG, Galmozzi E, De Nicola S, Cheroni C, Clark PJ, Ronchi G, Lampertico P, Colombo M.

Int J Mol Sci. 2014 Apr 25;15(5):7213-24. doi: 10.3390/ijms15057213.

15.

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.

Hsu CS, Liu CH, Liu CJ, Hsu SJ, Chen CL, Hwang JJ, Lai MY, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2010 May;25(5):970-7. doi: 10.1111/j.1440-1746.2009.06186.x.

PMID:
20546452
16.

Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M.

J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

PMID:
22863264
17.

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

Halangk J, Sarrazin C, Neumann K, Puhl G, Mueller T, Teuber G, Klinker H, Hinrichsen H, Buggisch P, Landt O, Weich V, Bergk A, Wiedenmann B, Neuhaus P, Berg T, Witt H.

J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23.

PMID:
18644651
18.

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.

Ydreborg M, Westin J, Rembeck K, Lindh M, Norrgren H, Holmberg A, Wejstål R, Norkrans G, Cardell K, Weiland O, Lagging M.

PLoS One. 2013 Nov 14;8(11):e80172. doi: 10.1371/journal.pone.0080172. eCollection 2013.

19.

KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.

Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE, Moliterno RA.

Hum Immunol. 2011 Nov;72(11):1074-8. doi: 10.1016/j.humimm.2011.08.017. Epub 2011 Aug 28.

PMID:
21920398
20.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk